MarketWatch |
Popis: MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.
|
||||||
Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss19:17 Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION. How SpaceX was able to avert one of the market’s biggest fears about its stock17:02 Some investors worried that SpaceX’s volatile stock would have an extreme impact on indexes, but the company’s staggered lockup schedule has mitigated this issue. ‘We had the worst fight we’ve ever had’: I want my husband to retire at 65. But I don’t want to lose his $280,000 salary.11:47 “We have about $2.6 million, most of it in his 401(k) and IRAs, plus $450,000 in a brokerage account and my own IRA.” |